Sandro Baleotti Rizoli
Sandro Baleotti Rizoli received his M.D. degree and completed a general surgery residency in Brazil. He then moved to Canada in 1992 where he underwent a second residency in general surgery followed by fellowships in trauma and critical care. During this time, he also completed the Ph.D. degree at the University of Toronto,Toronto, ON, Canada, under the supervision of Dr. Ori Rotstein. In July 2002, he became an Assistant Professor of surgery and critical care medicine at the Sunnybrook Health Sciences Centrethe, University of Toronto. Due to his interest in research, he soon became the Director of Trauma, Emergency and Critical Care Research at Sunnybrook Research Institute (Dr. Michael Julius). Dr. Rizoli research focuses on two major areas: the immunological and anti-inflammatory effects of hypertonic fluids and the physiopathology and management of hemorrhagic shock in trauma. In 2004, he completed the first randomized controlled trial (RCT) on the immunological effects of hypertonic fluids in trauma patients. Rizoli was awarded the 2006 Royal College Gold Medal in surgery for this work. He also participated in the first RCT on recombinant factor VIIa use in bleeding trauma patients. Sunnybrook has one of the largest clinical experiences with this therapy, and Dr. Rizoli and colleagues have 12 manuscripts on this topic. Another major area of interest is understanding and managing early coagulopathy in trauma. He has over 100 peer-reviewed publications in medical journals including the Journal of Biological Chemistry, Annals of Surgery, and Lancet Infectious Diseases. In addition, he was promoted to an Associate Professor in 2007, received the New Investigator award from the Canadian Institutes of Health Research (IHR/NovoNordisk), and has recently been awarded the De Souza Research Chair in Trauma. Rizoli is the Chief of Region XII of the Committee on Trauma of the American College of Surgeons.
Biography Updated on 1 June 2010